The understanding of the role of incretin hormones in the pathophysiology of hyperinsulinemic hypoglycemia is important for the exploration of the GLP-1 receptor as a therapeutic target for these conditions. The gene discussed is GIP; the disease is hyperinsulinemic hypoglycemia.